openPR Logo

Press Releases from SMi Group (888 total)

Agenda released for Drug Discovery 2017 : big pharma and biotech bridge the gap

Big pharma and biotech to meet in London conference on Drug Discovery, taking place on 27th & 28th March 2017 in London. The gap between a laboratory discovery and an approved drug on the market is a decade-long process of laboratory testing, evaluation in animal models, and human clinical trials that can cost hundreds of millions. Against this backdrop, SMi Group has launched Drug Discovery 2017, which aims to bridge

Multi-Organ-on-a-Chip Technologies: potential impact on predictive substance tes …

SMi has confirmed that TissUse, leading pioneers of the Multi-Organ-Chip technology, will be joining the expert speaker lineup for the inaugural conference on 3D Cell Culture. The event will be launched on the 22nd and 23rd of February 2017 in London. TissUse’s proprietary multi-organ-chip technology platform closely simulates human biology to achieve uniquely lifelike environments. Connected organs and close physiological context allow remarkably close resemblance to in vivo conditions. This

Industry and Government Bodies Gather for Crucial Updates into Antibiotic Resist …

Just 3 weeks remain until SMi Group open its doors to host Superbugs & Superdrugs USA, the American installment of its long running European conference. Following on from 18 years of expertise in pushing industry collaboration and knowledge to promote antibiotic drug discovery, the Superbugs & Superdrugs event will travel across the Atlantic for the first time to gather an audience of senior industry experts and leading government bodies to tackle

Challand Biosimilars Consulting joins Biosimilars North America event to provide …

SMi's 3rd annual Biosimilars North America conference will be returning to Iselin, New Jersey, USA in November 2016. This year’s event promises to bring even more senior experts discussing industry hot topics such as: latest approvals, biosimilar commercialization, interchangeability’s impact on biosimilars, regulatory updates and much more! SMi Group is delighted to announce: Rodeina Challand, Director, Challand Biosimilar Consulting joins the 3rd annual Bisoimilars North America conference. The regulatory pathways for the

NIAID Unveils First Year Results of US Government “Combating Antibiotic Resist …

NIAID Unveils First Year Results of US Government “Combating Antibiotic Resistant Behaviour (CARB) Initiative” at Superbugs USA In just over 4 weeks on November 14th & 15th, SMi Group will open its doors to host the highly anticipated conference on antimicrobial resistance (AMR) – Superbugs & Superdrugs USA 2016. By reaffirming the World Health Organisation’s “Global Action Plan on Antimicrobial Resistance” and recognizing the severe and imperative threat posed by AMR, a

Roche Unlock the Potential of Locked Nucleic Acids

SMi Group are thrilled to have industry expert Dr Bo Rode Hansen, present a special keynote address on harnessing the potential of locked nucleic acids at the 8th annual RNA Therapeutics conference. The established event set to take place on 22nd & 23rd February in Central London, will once again gather a global audience of scientific leaders, KOL's and drug development specialists, providing a focal point to discuss the future of

Myths that must be overcome to ensure successful commercialization of biosimilar …

SMi's 3rd annual Biosimilars North America conference will be returning to Iselin, New Jersey, USA in November 2016. This year’s event promises to bring even more senior experts discussing industry hot topics such as: latest approvals, biosimilar commercialization, interchangeability’s impact on biosimilars, regulatory updates and much more. In the run up to this must-attend show the SMi Group caught up with the conference speaker: Ross Day, Director of Pharmacy & Sourcing

Parallel Trade for Pharma: The opportunities and challenges ahead – beyond FMD …

SMi Group is delighted to announce: 11th annual Parallel Trade for Pharma will be returning to London in February 2017 after 10 successful years in the running! The meeting will gather 90+ selected senior leaders in parallel trade to discuss upcoming trends and share best practices. With Brexit and the new EU Falsified Medicine Directive, what does the future hold for parallel trade? The 11th annual event will discuss short term

Case study from Maersk Oil North Sea: Financing a major gas project in a challen …

Recently in the news: ” Maersk Oil begins first production well drilling at $4.5bn Culzean field in UK North Sea”.(Source: EBR, 30th Sep 2016) SMi Group is delighted to have Tom Tildesey, Chief Finance Officer, Maersk Oil North Sea UK giving an exclusive speech on financial aspect of major gas projects in a challenging climate. Tom Tildesey will discuss capital development: methods used by Maersk Oil, working with the government and minimising

Market Access Strategies – Pricing and Reimbursement Landscape in the European …

SMi Group reports: 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will be returning to London next week. Payers continue to play an important role in market access. Products are increasingly being rejected for reimbursement, adversely affecting the market share of these products. (Sourse: Medgadget, Sept 2016). SMi’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will gather leading industry experts next week in London to discuss the

Solving the last jigsaws to minimize risks, optimize costs and accelerate commer …

It's without doubts that the biosimilars market present lucrative opportunities for pharmaceuticals and biotech companies. Over the last 12 months, market participants have witnessed revolutionary steps in the US to facilitate commercialization. It is now time to meet your industry colleagues to discuss how to commercialize biosimilars, industry partnership and corporate strategy, interchangeability impact on biosimilars, regulatory updates and much more. SMi Group is delighted to have Edric Engert, Senior Vice

Critical Updates Showcased at Pre-Filled Syringes Europe 2017 by the MHRA, UCB, …

SMi Group are delighted to have the UK Medicines and Healthcare Products Agency (MHRA), present the latest updates on EU legislation in an opening address at Pre-Filled Syringes Europe, when it returns to Central London on 18th and 19th January 2017 for its 9th annual show. Vikas Jaitely, Deputy Manager and Senior Pharmaceutical Assessor from the MHRA Licensing Division, will provide attendees with a clearer understanding on the multi-faceted field of

Early Bird Discount for Biometrics Masterclass Expiring end of September

SMi Group Reports (2016.09.28, London, UK): Savings for Biometrics in Official Environments and the Future Masterclass expiring soon The £100 booking discount for SMi's security masterclass, Biometrics in Official Environments and the Future will expire on the 30th September 2016. This discount is available for all types of bookings and will be the last chance for attendees to save substantial money when booking their spot at this year’s event. This focused

Risk assessments in fungal spore and bacterial spore excursions

SMi Group reports: the 6th annual Pharmaceutical Microbiology conference will be returning to Holiday Inn Kensington Forum, London, UK on 18 – 19 January 2017. The event will gather leading microbiology experts to discuss hot industry topics such as contamination and endotoxins, quality assurance and control, environmental monitoring, new mechanisms of detection and much more. SMi group is delighted to have Jim Polarine, Senior Technical Service Manager, STERIS Corporation giving an exclusive

Interviews Released on Antibiotic Resistance with BARDA, Janssen and Blueberry T …

SMi Group release an exclusive series of interviews ahead of the Superbugs & Superdrugs USA Conference that will take place on Nov 14th and 15th. Running for 18 years in Europe, SMi Group's Superbugs & Superdrugs event will travel across the Atlantic Ocean for the first time to Iselin New Jersey following a high attendance of US delegates at the European show. The popularity of the event highlights the imminent

Biogen Talk Biosimilars in Keynote Address at Biosimilars Europe 2016

Following on from Biogen’s recent UK launch of its biosimilar drug for a range of chronic inflammatory conditions, SMi are thrilled to welcome them onto the agenda for Biosimilars Europe 2016. The newly added presentation from the Global Head Medical Affairs Biosimilars, Mourad Farouk Rezk, will discuss how to bring biosimilars closer to patients and healthcare professionals when the show returns to Central London on 29th & 30th September. The programme for

The RAF on Preparing ISR Operators for Current and Future Operations: Training D …

Effective training is vital for a robust and versatile ISR (Intelligence, Surveillance and Reconnaissance) capability. When developing the practices and technologies required for information superiority, leading military nations apply different techniques to train their Air Forces. Explore some of these cutting edge ideas at this year’s highly anticipated Airborne ISR conference, taking place in Central London on the 26th and 27th October 2016. Presentation on air ISR training by the

Meet Top 10+ pharma companies at European Pharmaceutical Market Access, Pricing …

SMi’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will be returning to London in 4 weeks. This year’s packed programme includes unique presentations, case studies and panel discussions delivered by leading experts. Speaker line-up and confirmed attendees in 2016 include: Acorda Therapeutics, Alcon Pharma GmbH, Amgen Inc., Astellas Pharma Europe, Boehringer Ingelheim, Lundbeck, IMS Health, Janssen Strategic Marketing, Novartis, Office of Health Economics, Otsuka Pharmaceuticals, Shire, Teva Pharmaceuticals, and

Agenda released for the highly anticipated 6th annual Pharmaceutical Microbiolog …

SMi proudly presents the return of the 6th annual Pharmaceutical Microbiology conference and exhibition to Holiday Inn Kensington Forum, London on 18 - 19 January 2017! The microbiology market has significantly grown in recent years as the demand from end user industries increases. The bacterial culture media segment accounted for the largest share of the global microbiology culture market in 2014. This segment is likely to continue its increased share until

The Most Prominent Updates in Biosimilars Discussed by Merck, Lupin, IMS Health …

Just three weeks remain until the medical industry gathers for SMi’s established Biosismilars Europe show which will return to Central London on 29th and 30th September for its 7th annual show. Programme highlights will include: • Discussions on critical developments in market access, commercialisation, p&r and the next decade of biosimilar drug development. • Updates in European, UK and US regulation. • A comparison on the correlation between biosimilars market share and price erosion of

3 Presentations on Tactical Communications by Hungarian Defence Forces, RUAG Def …

SMi reports (2016.09.06, London, United Kingdom): SMi Group have released online 3 presentations from the 9th annual Mobile Deployable Communications conference SMi Group have released for download, three presentations from this year’s Mobile Deployable Communications military conference. The available presentation include those from the Hungarian Defence Forces, RUAG Defence and XTAR LLC, entitled: ‘Simplifying All-IP Tactical Networks’, ‘Provision of Deployable CIS Capabilities by Hungary’ and ‘X-band has come of age!

Richard DiCicco from Harvest Moon Pharmaceuticals USA provides an Exclusive Inte …

It's without doubts that the biosimilars market present lucrative opportunities for pharmaceuticals and biotech companies. Over the last 12 months, market participants have witnessed revolutionary steps in the US to facilitate commercialization. The 3rd Annual Biosimilars North America conference will provide timely discussion with case studies on how to commercialize biosimilars, latest market developments and regulatory updates to ensure you stay at the forefront of this evolving market! In the run up

Santander, Sumitomo Mitsui Banking Corporation, ABN AMRO Bank, Standard Chartere …

SMi Group reports: The 3rd annual Project Financing in Oil and Gas conference will be returning to London on 21 – 22 November 2016. The Project Financing in Oil and Gas conference will offer all parties involved in financing oil and gas projects the perfect platform to dissect key challenges and latest developments in the industry. Hear from and network with the top banks in project financing for oil and gas, learn

MQ-9 users USA, UK, France, Netherlands and Spain will meet in London to discuss …

SMi reports (2016.08.23, London, UK): Learn about Spain’s MQ-9 procurement deal with Spanish MoD representative presenting at this year’s Airborne ISR IN THE NEWS: "Spain has moved forward with its procurement of unarmed MQ-9 Reapers after putting California-based remotely piloted aircraft manufacturer General Atomics Aeronautical Systems on contract for four aircraft and two Block 30 ground control stations." (Flight Global, 2016) Learn about the huge procurement deal with Spanish MoD representative, Colonel

Rafael, Lockheed Martin, Thales and Northrop Grumman meet in Prague to discuss A …

SMi reports (19.08.2016, London, UK): Leading defence vendors join the expert industry speaker line-up at the Air Missile Defence Technology conference this Autumn. SMi has confirmed new sponsor speakers for Air Missile Defence Technology 2016, which takes place on the 24th and 25th of October 2016 in Prague, Czech Republic. The new industry experts set to present at the conference include • Colonel (Ret'd) Gil Shalev, Business Development & Marketing Manager, Rafael •

Vaccination Induced Cellular Immunity – The Novel Therapy Breakthrough against …

SMi Group are delighted to have Farzin Farzaneh, Professor of Molecular Medicine at Kings College London, open the 2016 Cancer Vaccines congress when it returns to central London next month for its 5th annual show. Key pioneering work carried out by Professor Farzin Farzaneh and other leading scientists played a crucial role in supporting research for a new vaccine aimed at enabling the immune system to fight against advanced cancer. Earlier

Case studies on drug development and novel targets from Glenmark Pharmaceuticals …

SMi Group reports: Glenmark Pharmaceuticals and Novartis Pharma to join the speaker line up at this years’ COPD conference in London on 19-20th October. COPD 2016 will gather a global audience of respiratory professionals and lead scientists for a packed 2 day agenda. The event will take place on 19-20th October in London. Day 1 will address topics such as pre-clinical and clinical development, COPD exacerbations, advances in patient monitoring, while

Cancer Vaccines: Abzena and Genentech go Under the Microscope in Exclusive New I …

SMi's 5th annual Cancer Vaccines conference will return to London this autumn to showcase the latest advances in clinical breakthroughs. In the run up to the industry congress taking place on 21st and 22nd September, SMi Group caught up Abzena and Genentech to discuss current medical developments and their upcoming talks. Personalised therapy came up as an area showing most potential when asked about research demonstrating promise. Genetech’s Medical Director, Daejin Abidoye

John Rex to Give Exclusive Talk on the Crisis of Antimicrobial Resistance

Industry expert Dr John Rex will be presenting a special keynote address on the global crisis of antibiotic resistance at SMi’s Superbugs & Superdrugs congress this autumn. The industry meeting set to take place on Nov 14th and 15th in Iselin, New Jersey, will gather a global audience of scientific leaders, funding bodies and drug development specialists, providing a focal point to discuss funding opportunities and clinical advancements in drug discovery. With

Exclusive Access to Helicopter Presentations by Royal Netherlands Air Force, Swe …

SMi reports (2016.07.27, London, United Kingdom): SMi releases exclusive access to past military helicopter presentations SMi Group have released online three military presentations from the second event in their series of helicopter conferences: ‘Helicopter Technology Eastern Europe’, which was hosted in May this year. The unique presentations now available to download include those from the Royal Netherlands Air Force, Swedish Air Force, and European Personnel Recovery Centre, entitled: ‘Concept of Operations

CURRENT TRENDS IN HEALTH TECHNOLOGY ASSESMENT

SMi Group Reports: Quintiles, Alcon and Novartis to present their case studies on HTA at European Pharmaceutical Market Access, Pricing and Reimbursement (10 – 12 October 2016, Holiday Inn Kensington Forum, London, UK) The 22nd annual conference will gather industry experts to discuss current challenges in European market access, pricing and reimbursement, capture on emerging market's regulatory framework to adapt your market access and P&R models, cancer drug funding, budget cuts

Sandoz to Give Insight on European Biosimilar Trends at 7th Annual Congress

SMi Group are delighted to announce a new speaker for the two day event which will gather a global audience of biosimilar drug makers and regulatory experts this autumn. Dr Luis Borlido, Lab Head Characterization from Sandoz GmbH will join the notable line-up at the conference “Biosimilars Europe” when it returns to Central London for its 7th annual show. The presentation entitled: Recent Trends in the Development of Biosimilars and Evaluation of

How to finance your mega projects in such volatile market situation? Case Studie …

SMi reports (2016. 07.15, London, UK): Hear case studies from Maersk Oil North Sea UK and Genel Energy at the 3rd annual Project Financing Oil and Gas conference this November. SMi are pleased to announce that this years’ Project Financing in Oil and Gas conference will include case study presentations from Maersk Oil North Sea UK and Genel Energy. The exclusive case studies will be focused on oil and gas financing

Case studies on drug development and novel targets from Glenmark Pharmaceuticals …

SMi Group reports: Glenmark Pharmaceuticals and Novartis Pharma to join the speaker line up at this years’ COPD conference in London on 19-20th October. COPD 2016 will gather a global audience of respiratory professionals and lead scientists for a packed 2 day agenda. The event will take place on 19-20th October in London. Day 1 will address topics such as pre-clinical and clinical development, COPD exacerbations, advances in patient monitoring, while

How to commercialize Biosimilars? Case studies from Boehringer Ingelheim, EMD Se …

SMi Group: Biosimilars North America meeting will take place on November 16-17, 2016, New Jersey, USA. It's without doubts that the biosimilars market present lucrative opportunities for pharmaceuticals and biotech companies. Over the last 12 months, market participants have witnessed revolutionary steps in the US to facilitate commercialization. There are now 2 biosimilars approved, with a growing number expected to enter the market across a broad range of therapeutic areas

RBV Capital to explore venture capital partnerships in the orphan drugs industry

SMi Group reports (12.07.2016, London, UK): Venture capital fund partner joins expert speaker line-up at Orphan Drugs & Rare Diseases 2016 The industry established event “Orphan Drugs & Rare Diseases” returns to London on the 19th and 20th October 2016 for its 5th annual show. Robert Karl, Partner at RBV Capital, joins the list of expert speakers. In the run up to the event, SMi spoke to Mr Karl about industry

Thales strengthens commitment to cybersecurity | Hear more at MilSocialMedia2016

SMi Reports (London, UK): Thales have joined the speaker line-up for SMi Group’s 6th annual Social Media within the Defence & Military Sector in November. SMi is proud to announce that Thales have joined the 6th annual conference on Social Media Within the Defence & Military Sector as sponsors and will be presenting at the event which takes place on 14 & 15 November 2016 in Central London. Speaker details will

Agenda Released for Superbugs USA: PAHO/WHO, NIH, AstraZeneca, Pfizer and BARDA …

SMi have announced that a brochure has been released for Superbugs & Superdrugs USA, taking place on November 14th & 15th 2016 in Iselin, New Jersey. Aiming to provide solutions in funding drug development projects, as well as guidance on antibiotic alternatives and updates on global initiatives to fight infectious diseases, the agenda will look to arm attendees with an effective toolkit of ideas to fight the global attack against bacteria's

Biosimilars Europe: Looking Ahead into the New European Landscape

Case studies from both Switzerland and Norway on strategic management and switching studies with two keynotes from Merck Group and the Norwegian Medicines Agency. SMi are delighted to announce that both the Norwegian and Swiss markets will be represented at Biosimilars Europe when it returns to London for its 7th annual show on 29th and 30th September. Will the UK’s withdrawal from the European Union also translate into an unravelling of its

Interview released with UBC – An Express Scripts Company: Patient Recruitment …

SMi Group: Biosimilars North America meeting will take place on November 16-17, 2016, New Jersey, USA. In the run up to the event, the SMi Group caught up with Shazia Ahmad, Director, Patient & Physician Services, UBC - An Express Scripts Company. Shazia will be leading a pre-conference workshop on November 15th: “Leveraging Successful Patient Recruitment & Retention Strategies in Biosimilars Research”. In the exclusive interview, Shazia Ahmad said: "I believe one

Alexion to explore challenges in paediatric orphan drug development

SMi reports (29.06.2016, London, UK): Alexion Associate Director for Regulatory Affairs joins expert speaker line-up at the 5th Orphan Drugs and Rare Diseases event. SMi Group’s annual conference on Orphan Drugs and Rare Diseases returns to London for the 5th time on 19th-20th October 2016. Registration is live at http://www.orphandrugs-event.com/openpr. This year’s event will gather a global audience of experts to explore the latest innovations and technologies in orphan drug development

Future Pricing and Reimbursement strategies from ABPI, IMS Health, Baxalta, Shir …

SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will be running at Holiday Inn, Kensington Forum in London from 10-11 October 2016. Recently in the news: "On June 24, 2016, there was a historic decision - the United Kingdom voted to leave the European Union... What will be the impact on the pharma and biotech industry? First, the global big pharmaceutical companies that have major exposure to

Project Financing in Oil and Gas is returning to London this November. Join Maer …

SMi Group is delighted to announce that registration is now live for the 3rd annual Project Financing in Oil and Gas conference (21- 22 November 2016, Holiday Inn Kensington Forum, London, United Kingdom). In an increasingly volatile market with oil prices impacting liquidity across the world, industry experts are anticipating significant renovation of the project financing market. The event will gather industry professionals to share thoughts and ideas of how we

BARDA, NIH and Janssen to Present on Antimicrobial Resistance at Superbugs USA t …

SMi are delighted to announce the expansion of their antimicrobial portfolio of events across the Atlantic with the release of Superbugs & Superdrugs USA, complementing the Group’s Superbugs & Superdrugs European conference which has been running for the past 18 years. With pending confirmations from PAHO/WHO and Astra Zeneca, SMi Group have worked closely with a panel of speakers to present an agenda that will look to address key issues

Exclusive New Interview Released with Biontech RNA Pharmaceuticals Prior to Keyn …

SMi are delighted to have Dr. Mustafa Diken from Biontech RNA Pharmaceuticals GmbH, present at the 5th Annual Cancer Vaccines Conference when it returns to London on 21st-222nd September 2016. Dr. Mustafa Diken is the Deputy Vice President Immunotherapies and Preclinical Research for Biontech RNA Pharmaceuticals GmbH. His research mainly focuses on the development of novel cancer vaccines based on antigen-encoding messenger RNA (mRNA) and the elucidation of immunomodulatory mechanisms

Meet Respiratory Experts from Novartis, Chiesi, MedImmune and Mylan at COPD 2016

SMi Reports (2016.06.24, London, UK): The 8th annual COPD conference will be returning to London on 19 – 20 October 2016. Experts from Novartis, Chiesi, MedImmune, and Mylan will speak at this event. Earlier this year Novartis announced a collaboration with Qualcomm Incorporated through its subsidiary, Qualcomm Life, Inc., in digital innovation with the Breezhaler(TM) inhaler device to treat COPD. The Breezhaler(TM) inhaler device will enable patients to have access to

Receive European Pharmaceutical Pricing & Reimbursement updates from EMIG, EUCOP …

The UK's Department of Health has said there will be no further price cuts for branded medicines not funded via the voluntary Pharmaceutical Price Regulation Scheme (PPRS) in a move welcomed by the industry. The DH announced in November 2013 that it would reduce the cost of these statutory medicines by 15% as part of wider drug pricing negotiations and there were concerns that this would be reduced further for

Industry Survey: Pre-Filled Syringes and Medical Devices

SMi Group announces the launch of Industry Wide Survey for Pre-Filled Syringes and Medical Devices and invites industry professionals to take part in it. The survey launched with the purpose of preparing for the 6th Annual Pre-Filled Syringes Conference taking place in London on the 27th-28th of January 2014. The survey consists of 10 questions and will take less than 5 minutes to complete. All respondents will get a copy

Develop the right strategy following the advancement of pre-filled syringe syste …

The boom in biotechnology was undoubtedly a fundamental driver for pre-filled syringes. It decreases the chances of dosage errors, improving sterility, assuring patient compliance and removes cross-infection from re-usage of needles. It is no surprise that pre-filled syringes has become the leading platform for driving innovation and adding market value to the biopharmaceutical industry. These have been key factors in driving growth in the drug delivery and packaging industries with

SMi announces the 16th annual Generics and Patent Strategies London

SMi is pleased to announce the 16th annual Generics and Patent Strategies conference taking place in London from 13-14 May 2013. The conference will see world-renowned experts present the hottest topics and key challenges faced within the Generics industry today in combination with panel discussions, that will provide the latest updates on increasing profitability in a highly competitive market, how to overcome some of the IP issues faced when challenging

Go To Page:    11 12 13 14 15 16 17 18 19 20